Top Ten Equity Holdings and Exposures

RNS Number : 5280A
Polar Capital Global Health Tst PLC
02 February 2022
 

2nd February 2022

 

Polar Capital Global Healthcare Trust plc (the "Company")

 

Top Ten Equity Holdings and Sector and Geographic Exposure as at 31st January 2022 and full Portfolio listing as at 31st December 2021 available from company's website

 

Polar Capital Global Healthcare Trust plc is pleased to announce that as at 31st January 2022 the top ten equity holdings and the sector and geographic breakdown were as follows:

 

Top 10 Holdings 

%

Johnson & Johnson

8.3%

UnitedHealth Group

7.1%

AstraZeneca

5.0%

Abbott Laboratories

5.0%

Bristol Myers Squibb

3.9%

Horizon Pharma

3.3%

Cooper

3.2%

Steris

3.0%

Sanofi

3.0%

Hologic

3.0%

Total

45.0%

 

Sector Exposure

%

Healthcare Equipment

25.1%

Pharmaceuticals

22.8%

Biotechnology

19.1%

Managed Healthcare

10.0%

Healthcare Supplies

8.3%

Healthcare Facilities

6.0%

Life Sciences Tools & Services

5.4%

Metal & Glass Containers

2.8%

Healthcare Distributors

2.3%

Healthcare Technology

1.7%

Healthcare Services

0.9%

Cash

-4.4%

Total

100.0%

 

Geographic Exposure

%

United States

78.8%

United Kingdom

7.1%

France

3.0%

Switzerland

3.0%

Denmark

2.9%

Germany

2.2%

Belgium

2.1%

Netherlands

2.1%

Ireland

1.7%

Japan

1.6%

Cash

-4.4%

Total

100.0%

 

 

 

Gearing Ratio as calculated in accordance with the guidelines of the Association of Investment Companies, was 4.4%. Gearing is made up of structural debt provided by the subsidiary company PCGH ZDP plc, through the issue of zero dividend preference (ZDP) shares.

 

The ZDP asset cover as at 31st January 2022 was 10.40x. This ratio is calculated by dividing the Company's net asset value, adjusted to add back the current value of the structural debt, by the final redemption value of the ZDP shares.

 

 

The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.co m

 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUUPUQCPUPPGMP
UK 100